(+977) 4110791, 01-4110761 info@opl.com.np
PREGNO A blessing for her

Generic Name:               Mifepristone

Therapeutic Category:  Anti –progesterone/ Abortifacient

Composition: Each uncoated tablet contains Mifepristone 200 mg

Pregnancy Category:                    X

Presentation: Available in the pack size as 1 tablet X 1 blister

Description

Mifepristone, also known as RU-486, is a medication typically used with misoprostol to bring about an abortion. This combination is more than 95% effective during the first 50 days of pregnancy. It is also effective in the second trimester of pregnancy. Effectiveness should be verified two weeks after use. It is taken by mouth.

Mechanism of Action

Mifepristone blocks the action of progesterone, which is needed to sustain a pregnancy. This results in:

  • Changes in the uterine lining and detachment of the pregnancy
  • Softening and opening of the cervix
  • Increased uterine sensitivity to prostaglandin(misoprostol)

Indications

  • Medical termination of pregnancy

 

Treatment regimen with mifepristone/misoprostol

Clinical studies have shown that several variations in mifepristone/misoprostol treatment regimens are safe and effective. Generally, however, once a woman has decided to have a medical abortion, there are three steps in the process of a medical abortion:

Step One (at the medical office or clinic)

  • A medical history is taken and a clinical exam and lab tests are performed.
  • Counseling is completed and informed consent is obtained.
  • If eligible for medical abortion, the woman swallows the mifepristone pill(s).

Step Two (at the office/clinic or at home depending on the treatment regimen)

  • This step takes place within about 2 days of step one.
  • Unless abortion has occurred and has been confirmed by the clinician, the woman uses misoprostol. Misoprostol tablets may be swallowed, placed between cheek and gum, or inserted into the vagina, depending on the treatment regimen.

Step Three (at the office or clinic)

  • This step takes place within about 2 weeks of step two.
  • The clinician evaluates the woman to confirm a complete abortion. It is essential for women to return to the office/clinic to confirm that the abortion is complete.
  • If there is an ongoing pregnancy, a suction abortion should be provided.

How effective is the combination of mifepristone and misoprostol in terminating an early pregnancy?

Depending on the prescribing physician’s protocols, mifepristone and misoprostol can be used for early abortion up to 63 days after the start of the last menstrual period. Approximately 95-98% of women will have a complete abortion when using mifepristone/misoprostol. Success rates may depend on the treatment regimen and the duration of the pregnancy. The remaining women will need a suction procedure, either because of ongoing or excessive bleeding, an incomplete abortion (tissue remains in the uterus but there is no growing embryo), or an ongoing pregnancy (a viable growing pregnancy, which occurs in less than 1% of cases).

Pharmacokinetics

Absorption: Absolute bioavailability 69%

Protein binding: Approximately 98%

Metabolism: Hepatic

Route of elimination: Fecal

Half-life: The concentration decreasing by a half between about 12 and 72 hours, and then more rapid, giving an elimination half-life of 18 hours.

Adverse Effects

  • Abdominal pain, uterine cramping, and vaginal bleeding or spotting for an average of 9–16 days.
  • Nausea, vomiting, diarrhea, dizziness, fatigue, and fever
  • Pelvic inflammatory disease is a very rare but serious complication.

Contraindications

PREGNO is contraindicated in the following populations and situations:

  • Suspected ectopic pregnancy*
  • Intrauterine device
  • Chronic adrenal failure
  • Hemorrhagic disorder*
  • Inherited porphyria*

Precautions

  • Bleeding
  • Pregnancy termination confirmation
  • Serious bacterial infection

*Terminologies:

Ectopic Pregnancy: Also known as tubal pregnancy is a complication of pregnancy in which the embryo attaches outside the uterus.

Hemorrhagic Disorders: Spontaneous or near spontaneous bleeding caused by a defect in clotting mechanisms or another abnormality causing a structural flaw in the blood vessels.

Inherited porphyria: Refers to a group of disorders that result from a buildup of natural chemicals that produce porphyrin in your body.